Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.626,97
0,22%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Syneos Health Inc (SYNH) Syneos Health Inc (SYNH) Notizie

SYNH

Syneos Health (SYNH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SYNH
DataOraFonteTitoloSimboloCompagnia
29/04/202415:00PR Newswire (US)Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S.NASDAQ:SYNHSyneos Health Inc
12/04/202415:00PR Newswire (US)Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual MeetingNASDAQ:SYNHSyneos Health Inc
08/04/202415:00PR Newswire (US)Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone)NASDAQ:SYNHSyneos Health Inc
10/10/202312:08Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SYNHSyneos Health Inc
03/10/202314:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SYNHSyneos Health Inc
28/09/202323:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYNHSyneos Health Inc
28/09/202318:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SYNHSyneos Health Inc
28/09/202316:24GlobeNewswire Inc.Syneos Health Closes Transaction with Private Investment FirmsNASDAQ:SYNHSyneos Health Inc
26/09/202323:41PR Newswire (US)Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600NASDAQ:SYNHSyneos Health Inc
26/09/202313:30GlobeNewswire Inc.Syneos Health Names Terttu Haring President, Clinical Sites & PatientsNASDAQ:SYNHSyneos Health Inc
26/09/202311:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH)NASDAQ:SYNHSyneos Health Inc
12/09/202313:30GlobeNewswire Inc.Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health EquityNASDAQ:SYNHSyneos Health Inc
06/09/202313:54GlobeNewswire Inc.Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured NotesNASDAQ:SYNHSyneos Health Inc
11/08/202311:45PR Newswire (US)SYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos Shareholders of a Lead Plaintiff Deadline of September 25, 2023NASDAQ:SYNHSyneos Health Inc
02/08/202314:47GlobeNewswire Inc.Syneos Health Stockholders Approve Agreement with Private Investment ConsortiumNASDAQ:SYNHSyneos Health Inc
26/07/202323:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SYNHSyneos Health Inc
10/07/202313:30GlobeNewswire Inc.Syneos Health Appoints Hillary Bochniak as Chief Human Resources OfficerNASDAQ:SYNHSyneos Health Inc
07/07/202323:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYNHSyneos Health Inc
27/06/202323:13Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SYNHSyneos Health Inc
26/06/202313:30GlobeNewswire Inc.Syneos Health and uMotif Partner to Deliver Patient-centric eClinical PlatformNASDAQ:SYNHSyneos Health Inc
16/06/202323:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SYNHSyneos Health Inc
15/06/202312:26Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SYNHSyneos Health Inc
09/06/202316:15Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:SYNHSyneos Health Inc
25/05/202313:30GlobeNewswire Inc.Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health EquityNASDAQ:SYNHSyneos Health Inc
17/05/202313:30GlobeNewswire Inc.Syneos Health Leaders Recognized by HBANASDAQ:SYNHSyneos Health Inc
16/05/202314:05GlobeNewswire Inc.Syneos Health Leaders Recognized as PM360 2023 ELITE Award RecipientsNASDAQ:SYNHSyneos Health Inc
15/05/202314:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SYNHSyneos Health Inc
10/05/202321:01PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Syneos Health, Inc.NASDAQ:SYNHSyneos Health Inc
10/05/202313:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SYNHSyneos Health Inc
10/05/202313:07GlobeNewswire Inc.Syneos Health Reports First Quarter 2023 ResultsNASDAQ:SYNHSyneos Health Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SYNH

La tua Cronologia

NYSE
WWAV.B
TSXV
GASX.WT.A
NG Energy
BOV
TAEE4F
TAESA PN
COIN
GXCETH
GXChain
BIT
UB30EK
UniCredit Bank
BIT
I05841
Banca Imi
COIN
ORCAEUR
LATK
MCUSDT
Merit Circle [OLD]
BIT
F24935
Vontobel Financial Produ...
CSE
JBR
James Bay Resources
NASDAQ
AKBA
Akebia Therapeutics
LSE
81SO
Sg Issuer 28
NASDAQ
IMRA
IMARA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network